Amneal FDA Wednesday, December 11, 1974 +0.20 Positive

FDA Approves CHLOROQUINE PHOSPHATE — Amneal Pharmaceuticals of New York LLC

The FDA has approved Amneal Pharmaceuticals of New York LLC’s generic Chloroquine Phosphate, expanding access to this generic oral formulation. This approval is expected to exert additional price pressure on existing branded competitors in the market.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed